| Pierre Edouard De Delva, MD | |
|
2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216-4500 | |
| (601) 984-5170 | |
| Not Available |
| Full Name | Pierre Edouard De Delva |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043294432 | NPI | - | NPPES |
| P01195517 | Other | MS | RAILROAD MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD441215 (Pennsylvania) | Secondary |
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 21552 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Mississippi Med Center | Jackson, MS | Hospital |
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Dominic Medical Associates Llc | 0446303168 | 154 |
| State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
In this post in USAID's "IMPACTblog," Kirsten Gagnaire, global partnership director of the Mobile Alliance for Maternal Action (MAMA), discusses the program's operations in Bangladesh.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
A study of 89 patients at one U.S. hospital has found that "doctors and patients are often not on the same page when discussing diagnoses and treatment," Reuters reports. "In interviews with the patients on the day of their discharge, researchers found that only 18 percent even knew the name of the main physician in charge of their hospital care.
› Verified 6 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
In this post in USAID's "IMPACTblog," Kirsten Gagnaire, global partnership director of the Mobile Alliance for Maternal Action (MAMA), discusses the program's operations in Bangladesh.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
A study of 89 patients at one U.S. hospital has found that "doctors and patients are often not on the same page when discussing diagnoses and treatment," Reuters reports. "In interviews with the patients on the day of their discharge, researchers found that only 18 percent even knew the name of the main physician in charge of their hospital care.
› Verified 6 days ago
| Entity Name | St. Dominic Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407920549 PECOS PAC ID: 0446303168 Enrollment ID: O20090728000821 |
News Archive
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
In this post in USAID's "IMPACTblog," Kirsten Gagnaire, global partnership director of the Mobile Alliance for Maternal Action (MAMA), discusses the program's operations in Bangladesh.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
A study of 89 patients at one U.S. hospital has found that "doctors and patients are often not on the same page when discussing diagnoses and treatment," Reuters reports. "In interviews with the patients on the day of their discharge, researchers found that only 18 percent even knew the name of the main physician in charge of their hospital care.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pierre Edouard De Delva, MD 2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216-4500 Ph: (601) 984-5170 | Pierre Edouard De Delva, MD 2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216-4500 Ph: (601) 984-5170 |
News Archive
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
In this post in USAID's "IMPACTblog," Kirsten Gagnaire, global partnership director of the Mobile Alliance for Maternal Action (MAMA), discusses the program's operations in Bangladesh.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
A study of 89 patients at one U.S. hospital has found that "doctors and patients are often not on the same page when discussing diagnoses and treatment," Reuters reports. "In interviews with the patients on the day of their discharge, researchers found that only 18 percent even knew the name of the main physician in charge of their hospital care.
› Verified 6 days ago
Dr. Richard P Cochran, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 406-640-4933 | |
Dr. Lawrence Lee Creswell, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5170 Fax: 601-984-5198 | |
Dr. Craig Vorpe Adams, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 501 Marshall St Ste 104, Jackson, MS 39202 Phone: 601-969-6404 Fax: 601-973-4541 | |
Dr. Ali Dodge-khatami, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Division Of Pediatric Cardiac Surgery, Jackson, MS 39216 Phone: 601-984-4693 | |
Dr. Charles S O'mara, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5105 Fax: 601-815-3322 | |
Dr. Albert Michael Koury, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 501 Marshall St, Suite 100, Jackson, MS 39202 Phone: 601-969-7467 Fax: 601-948-1417 | |
Mr. Fidel Fabian Sendra, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1860 Chadwick Dr Ste 256, Jackson, MS 39204 Phone: 601-376-1394 |